JS

Jeff Sherman

Jeff Sherman


Chief Financial Officer



Professional Overview
Jeff Sherman is an experienced financial executive with a proven track record of driving strategic growth and operational excellence across the healthcare industry. As the Chief Financial Officer of NeoGenomics Laboratories, he leverages his extensive expertise in financial planning, risk management, and M&A integration to support the company's mission of advancing precision medicine.

Experience Summary

Current Role
As the Chief Financial Officer of NeoGenomics Laboratories, Jeff is responsible for overseeing the company's financial strategy, reporting, and compliance. He plays a pivotal role in securing funding, managing capital allocation, and driving financial optimization to support the organization's ambitious growth objectives. Under his leadership, NeoGenomics has strengthened its financial position and expanded its market presence.

Career Progression
Prior to his current role, Jeff served as the Chief Financial Officer at Privia Health, where he played a key part in the company's successful IPO. Before that, he held the CFO position at HMS Holdings Corp. (HMSY), where he spearheaded strategic initiatives that enhanced operational efficiency and profitability. Jeff's career includes senior financial roles at AccentCare, Inc., LifePoint Hospitals, and Tenet Healthcare, where he consistently demonstrated his ability to navigate complex financial challenges and drive sustainable growth.

Academic Background
Jeff holds a Bachelor of Science in Accounting from the University of Texas at Arlington, where he graduated with honors. He is a Certified Public Accountant (CPA) and has completed executive leadership programs at prestigious institutions, further enhancing his financial acumen and strategic decision-making capabilities.

Areas of Expertise
  • Financial planning and analysis

  • Capital structure optimization

  • Mergers, acquisitions, and integration

  • Risk management and compliance

  • Healthcare industry expertise

  • Strategic decision-making and leadership


Professional Impact
Throughout his career, Jeff has been instrumental in driving financial transformations and delivering sustainable growth for leading healthcare organizations. His contributions have resulted in improved profitability, enhanced market positioning, and increased shareholder value. Jeff is widely recognized as a trusted financial steward and strategic partner who consistently delivers exceptional results.

Conclusion
With his extensive experience, strong financial expertise, and deep industry knowledge, Jeff Sherman is poised to continue making a significant impact as the Chief Financial Officer of NeoGenomics Laboratories. His commitment to driving innovation, optimizing financial performance, and supporting the company's mission make him a valuable asset to the organization and the healthcare sector as a whole.